Hemodynamic and metabolic effects of angiotensin II on the liver

Peptides

Volumn 26, Issue 2, 2005, Pages 315-322

  Nascimento, Écio Alves ^a   Gioli Pereira, Luciana ^b   Carvalho, Leda Teixeira ^b   Santos, Edson Lucas ^b   Pesquero, João Bosco ^b   Kouyoumdjian, Maria ^b   Borges, Durval Rosa ^b  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin; Angiotensin receptor; Angiotensin converting enzyme; Bivascular liver perfusion; Losartan; Portal hypertension

Indexed keywords

CAPTOPRIL; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCONEOGENESIS; LIVER CELL; LIVER MICROSOME METABOLISM; LIVER PERFUSION; MALE; MEDICAL ASSESSMENT; METABOLIC REGULATION; NONHUMAN; OXYGEN CONSUMPTION; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; STELLATE CELL;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; HEPATOCYTES; KINETICS; KUPFFER CELLS; LIVER; LIVER CIRCULATION; LOSARTAN; MALE; OXYGEN CONSUMPTION; PERFUSION; RATS; RATS, WISTAR;

EID: 11144239646     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.09.017     Document Type: Article

References (22)

1. R. Bataller, P. Sancho-Bru, P. Gines, J.M. Lora, A. Al-Garawi, and M. Sole Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II Gastroenterology 125 2003 117 125
2. R. Blomhoff, and T. Berg Isolation and cultivation of rat liver stellate cells Methods Enzymol 190 1990 58 71
3. D.R. Borges, and M. Kouyoumdjian The recognition factor for clearance of plasma kallikrein is located on its heavy chain and not exposed on prokallikrein J Hepatol 16 1992 115 121
4. D.R. Borges, E.A. Limaos, J.L. Prado, and AC.M. Camargo Catabolism of vasoactive polypeptides by perfused rat liver Naunyn Schmiedebergs Arch Pharmacol 295 1976 33 40
5. A. Bracht, M. Kouyoumdjian, E.L. Ishii-Iwamoto, and D.R. Borges Indicator injections and pressure monitoring as complementary tools for investigating microcirculatory changes in the liver Trends Comp Biochem Physiol 9 2002 1 16
6. E.P. Brass, and M.J. Garrity Effect of nonsteroidal anti-inflammatory drugs on glycogenolysis in isolated hepatocytes Br J Pharmacol 86 1985 491 496
7. C.P. Campanile, J.K. Crane, M.J. Peach, and J.C. Garrison The hepatic angiotensin II receptor 1. Characterization of the membrane-binding site and correlation with physiological response in hepatocytes J Biol Chem 257 1982 4951 4968
8. D. Chan, L. Gera, J. Stewart, B. Helfrich, M. Verella-Garcia, and G. Johnson Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism Proc Natl Acad Sci USA 99 2002 4608 4613
9. 1 receptors are essentially identical Biochem Biophys Res Commun 197 1993 440 449
10. M. del Carmen Caro, M. Montiel, and E. Jiménez Characterization of the functional angiotensin II-receptor complex isoform in rat liver plasma membrane Life Sci 62 1998 51 57
11. L. Gioli-Pereira, E.A. Nascimento, A. Bracht, E.L. Santos, J.B. Pesquero, and M.A. Juliano Portal response to arterial administration of bradykinin into the liver Hepatology 38 2003 196A
12. International Guiding Principles for Biomedical Research Involving Animals by the Council for International Organizations of Medical Sciences (CIOMS). Geneva, Switzerland; 1985. p. 1-28.
13. M. Jacob, I. Bjarnason, S. Rafi, J. Wrigglesworth, and R.J. Simpson A study of the effects of indometacin on liver mitochondria from rats, mice and humans Aliment Pharmacol Ther 15 2001 1837 1842
14. K. Kaneda, W. Ekataksin, M. Sogawa, A. Matsumura, A. Cho, and N. Kawada Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction Hepatology 27 1998 735 747
15. C. Krämer, J. Sunkomat, J. Witte, M. Luchtefeld, M. Walden, and B. Schmidt Angiotensin II receptor-independent anti-inflammatory and antiaggegatory properties of losartan: role of the active metabolite EXP3179 Circ Res 90 2002 770 776
16. H.M. McConnel, J.C. Owicki, J.W. Parce, D.L. Miller, G.T. Baxter, and H.G. Wada The cytosensor microphysiometer: biological applications of silicon technology Science 257 1992 1906 1912
17. 1-receptor blockers in isolated vessels of different origin Hypertension 33 1999 1406 1413
18. F. Reisenleiter, N. Katz, and A. Gardemann Control of hepatic carbohydrate metabolism and haemodynamics in perfused rat liver by arterial and portal angiotensin II Eur J Gastroenterol Hepatol 8 1996 279 286
19. A.H. Schmaier The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction Am J Physiol Regul Integr Comp Physiol 85 2003 1 13
20. M. Schepke, E. Werner, E. Biecker, P. Schiedermaier, J. Heller, and M. Neef Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension Gastroenterology 121 2001 389 395
21. A.W. Schneider, J.F. Kalk, and C.P. Klein Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis Hepatology 29 1999 334 339
22. F. Suzuki-Kemmelmeier, E.L. Ishii-Iwamoto, and A. Bracht Metabolism of fructose in the bivascularly perfused rat liver Biochim Biophys Acta 1116 1992 275 282